Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 42 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 31 | 1,279−3.9%/yr | −3.9%/yr | 5.61.8× | 16% | 1,510 in 2030+2.8%/yr |
| Lumbar fusion | 27 | 1,165−2.8%/yr | −2.8%/yr | 5.11.8× | 1% | 1,160 in 2030−0.1%/yr |
| Kyphoplasty & vertebroplasty | 8 | 520−2.1%/yr | −2.1%/yr | 2.32.7× | 89% | 620 in 2030+3%/yr |
| Cervical fusion & disc arthroplasty | 9 | 439−3.4%/yr | −3.4%/yr | 1.91.6× | 17% | 560 in 2030+4.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 146 | 24,0660%/yr | 0%/yr | 104.71.1× | 45% | 29,100 in 2030+3.2%/yr |
| Skin substitutes & wound grafts | 18 | 5,940+21%/yr | +21%/yr | 16.21.3× | 77% | 5,190 in 2030−2.2%/yr |
| Bone graft & orthobiologics | 7 | 330−1.7%/yr | −1.7%/yr | 1.51.9× | 5% | 420 in 2030+4.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 70 | 6,327+1.2%/yr | +1.2%/yr | 27.53.0× | 82% | 7,570 in 2030+3%/yr |
| Spinal cord & DRG stimulation | 9 | 400+6.6%/yr | +6.6%/yr | 1.73.0× | 75% | 450 in 2030+2.2%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 1 | 290+14%/yr | +14%/yr | 1.21.3× | 60% | 570 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Superficial venous ablation | 15 | 962−9.3%/yr | −9.3%/yr | 4.20.7× | 92% | 750 in 2030−4%/yr |
| Peripheral arterial intervention | 6 | 843+4%/yr | +4%/yr | 3.70.7× | 48% | 190 in 2030−22%/yr |
| Dialysis access | 9 | 647−6.1%/yr | −6.1%/yr | 3.10.6× | 40% | 580 in 2030−1.7%/yr |
| Thrombectomy, IVC filters & venous stents | 0 | 253+3.2%/yr | +3.2%/yr | 1.20.9× | 0% | 480 in 2030+11%/yr |
| Carotid revascularization | 2 | 170−2.8%/yr | −2.8%/yr | 0.80.9× | 0% | 110 in 2030−6.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 25 | 1,792+0.1%/yr | +0.1%/yr | 8.71.5× | 7% | 1,820 in 2030+0.3%/yr |
| Cholecystectomy & appendectomy | 13 | 952−6.8%/yr | −6.8%/yr | 4.51.2× | 2% | 1,140 in 2030+3%/yr |
| Colorectal resection | 1 | 352−0.3%/yr | −0.3%/yr | 1.61.2× | 0% | 360 in 2030+0.4%/yr |
| Antireflux & hiatal hernia surgery | 3 | 239−2.8%/yr | −2.8%/yr | 1.11.6× | 0% | 170 in 2030−5.1%/yr |
| Breast reconstruction | 0 | 128−2.1%/yr | −2.1%/yr | 0.61.5× | 0% | 650 in 2030+31%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 33 | 1,327−4.4%/yr | −4.4%/yr | 6.11.7× | 22% | 1,410 in 2030+1%/yr |
| BPH procedures | 29 | 1,113−15%/yr | −15%/yr | 5.11.1× | 14% | 1,080 in 2030−0.5%/yr |
| Incontinence, prolapse & sacral neuromodulation | 6 | 487−2.4%/yr | −2.4%/yr | 2.21.2× | 7% | 610 in 2030+3.9%/yr |
| Hysterectomy, hysteroscopy & ablation | 2 | 384−2.1%/yr | −2.1%/yr | 1.90.8× | 11% | 380 in 2030−0.1%/yr |
| Prostatectomy & nephrectomy | 3 | 285+1.5%/yr | +1.5%/yr | 1.41.2× | 0% | 440 in 2030+7.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 10 | 862−3.8%/yr | −3.8%/yr | 4.00.9× | 83% | 1,410 in 2030+8.5%/yr |
| Sleep apnea & airway implants | 3 | 142+112%/yr | +112%/yr | 0.64.5× | 0% | 80 in 2030−8.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 20 | 1,028−3.6%/yr | −3.6%/yr | 5.00.8× | 9% | 990 in 2030−0.7%/yr |
| Tumor ablation | 1 | 173+29%/yr | +29%/yr | 0.83.1× | 79% | 280 in 2030+8.3%/yr |
| Tumor & fibroid embolization | 2 | 100−2.9%/yr | −2.9%/yr | 0.50.8× | 38% | 190 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 44 | 6,339+36%/yr | +36%/yr | 28.41.4× | 86% | 10,700 in 2030+9.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| EP ablation | 20 | 1,253+6.8%/yr | +6.8%/yr | 4.81.6× | 0% | 2,180 in 2030+9.7%/yr |
| Pacemaker, ICD & CRT implantation | 22 | 921−2.8%/yr | −2.8%/yr | 4.41.1× | 0% | 900 in 2030−0.4%/yr |
| LAA occlusion & loop recorders | 21 | 682+17%/yr | +17%/yr | 2.71.0× | 16% | 1,130 in 2030+8.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 33 | 1,541−5.4%/yr | −5.4%/yr | 5.71.3× | 0% | 1,540 in 20300%/yr |
| Structural heart (TAVR, TEER) | 21 | 422−1.7%/yr | −1.7%/yr | 1.61.1× | 0% | 410 in 2030−0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 2 | 108+8.1%/yr | +8.1%/yr | 0.51.3× | 0% | 180 in 2030+9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 100 | 16,336−0.9%/yr | −0.9%/yr | 73.31.6× | 75% | 15,600 in 2030−0.8%/yr |
| Vitreoretinal surgery | 15 | 1,023−2.3%/yr | −2.3%/yr | 4.71.8× | 59% | 990 in 2030−0.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 118 | 24,136−2.4%/yr | −2.4%/yr | 114.81.1× | 32% | 23,500 in 2030−0.5%/yr |
| ERCP & endoscopic ultrasound | 12 | 445−6.8%/yr | −6.8%/yr | 2.10.6× | 0% | 480 in 2030+1.3%/yr |
| Bronchoscopy & lung nodule | 6 | 444+15%/yr | +15%/yr | 2.10.8× | 0% | 960 in 2030+14%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.